Ultrasonic Surgical Aspirator to Treat Deep Infrabony Defects: A New Flapless Minimally Invasive Approach by C. Ghezzi et al.
Clinical Study
Ultrasonic Surgical Aspirator to Treat Deep Infrabony Defects:
A New Flapless Minimally Invasive Approach
Carlo Ghezzi,1 Camilla Donghi,1 Luca Ferrantino ,2 Elena Varoni ,3
and Giovanni Lodi 3
1Private Practice, Via Verdi 4, Settimo Milanese, 20019 Milan, Italy
2Department of Oral Rehabilitation, Istituto Stomatologico Italiano, University of Milan, Milan, Italy
3Department of Biomedical, Surgical and Dental Sciences, Universita` Degli Studi di Milano, Milan, Italy
Correspondence should be addressed to Luca Ferrantino; luca.ferrantino@gmail.com
Received 8 February 2018; Revised 25 May 2018; Accepted 2 June 2018; Published 29 July 2018
Academic Editor: Atsutoshi Yoshimura
Copyright© 2018CarloGhezzi et al.*is is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
*e primary outcome of the present study was to assess the percentage of pocket closure, and the secondary aim was to evaluate
the clinical performance in terms of clinical attachment level (CAL) gain, probing pocket depth (PPD) reduction, and gingival
recession (REC) after the use of cavitron ultrasonic surgical aspirator (CUSA) in deep infrabony defects. Fourteen deep infrabony
defects in 11 patients who were previously treated with active periodontal therapy followed by one year of supportive periodontal
therapy (at least three sessions) were additionally treated by the aid of CUSA. Eighty-six percent of the initial defects (12 out of 14)
resulted in a PD< 5mm, showing complete resolution six months after CUSA treatment, without any adverse event and with
negligible pain (VAS from 0 to 3). CUSA showed potential as a method to promote pocket healing, reduce PPD, and increase
clinical attachment (P< 0.001) in deep infrabony defects. *is trial is registered with ClinicalTrials.gov NCT03567161.
1. Introduction
Deep periodontal pockets, which are associated with
infrabony defects, are speciﬁc risk factors for periodontal
disease progression and tooth loss [1, 2]. In the past, the
interest of researchers on regeneration focused to develop
materials as a type of bone substitute and membrane or
biological mediator to improve result in tissue regeneration
[3–6], but recently, interest has been moving to the tissue
management to achieve better result introducing the min-
imally invasive surgical approaches (MIS) [7–13].
*e innovative aspects of the MIS technique are rep-
resented by a ﬂap design [12–18] to permit preservation of
interdental space, minimizing vertical release in order to
obtain adhesion andmaturation with slight trauma, together
with primary intention wound closure to achieve peri-
odontal tissue regeneration [11, 17–24].
In this context, we have to consider other new studies in
which authors deﬁne and compare the performance of the
minimally invasive nonsurgical technique (MINST) to the
minimally invasive surgical approach [25]. MINST has been
introduced as a concept that aims at obtaining extensive
subgingival debridement with a retention of the preoperative
gingival architecture, creating a minimal wound, and gentle
handling of the soft and hard tissues to stimulate the for-
mation of a stable blood clot by natural ﬁlling of the
infrabony defect [25–28].
Cavitron ultrasonic surgical aspirator (CUSA) is a
well-known technology that is used in medicine for dif-
ferent purposes; its most frequent applications are in
neurosurgery and liver disease [29–31]. CUSA has proven
to be eﬀective in bioﬁlm disruption and cell stimulation
[32]. *e hypothesis is that the employment of CUSA for
nonsurgical treatment of infrabony defects, thanks to its
abilities to disrupt, fragment, and aspirate granulation
tissue, will allow the formation of larger and more stable
blood clot.
*e purpose of this study was to test CUSA in non-
surgical treatment of infrabony defects to promote pocket
closure.
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2. Materials and Methods
*is was a Phase 2 noncontrolled clinical trial performed on
patients with infrabony defects to test whether the em-
ployment of CUSA for treating periodontal patients.
(1) provides beneﬁts in terms of a PD reduction and
CAL gain;
(2) is comfortable for both the patient and the operator;
(3) is free from adverse events.
All subjects included in the study were consecutive
periodontal patients attending a private clinic in Settimo
Milanese (Milan, Italy) who were treated by two operators
(CG and CD) with a similar experience in nonsurgical
produce who performed a speciﬁc training for CUSA on
a periodontal model. *ey were selected on the basis of the
following criteria.
Inclusion Criteria
(1) Having received a diagnosis of chronic periodon-
titis (Armitage 1999)
(2) Being treated by full-mouth debridement and
supportive periodontal treatment (SPT) in the last
year (at least three sessions) by one of the authors
(3) Having at least one residual pocket ≥5mm with an
intrabony component at least ≥2mm
Exclusion Criteria
(1) Smoking more than 10 cigarettes per day
(2) Pregnancy
(3) Irregular compliance during SPT in the last year
(4) Systemic conditions or therapies known to aﬀect
the healing potential of periodontal tissues
(e.g., uncontrolled diabetes, oncological conditions,
and immunosuppressant drugs)
All patients were informed on the objective of the studies
and provided informed consent.
*e clinical procedure was always performed in a single
session. Before intervention, all cases received local anaes-
thesia with 1 :100,000 mepivacaine. All residual pockets≥5mm underwent the following:
(1) Ultrasonic debridement: to minimize trauma to
the soft tissues, we used piezoelectric devices with
speciﬁc thin and delicate tips (EMS Electro Medical
Systems S.A. Chemin de la Vuarpillie`re, 31 1260,
Lyon, Switzerland).
(2) Flapless treatment: according to the anatomy of
the osseous sites, the sonotrode (Sonocare 300,
So¨ring GmbH, Justus-von-Liebig-Ring 2-25451
Quickborn, Germany) was inserted both intra-
sulcularly and transgingivally (smallest tip is
0.8 mm): intrasulcularly, in the cases of three wall
defects, and transgingivally in cases of one to two
wall defects (Figure 1). *e stack of piezoelectric
quartzes transforms the electrical energy from the
generator into a longitudinal, mechanical vibra-
tion of the sonotrode tip (Figures 2–4). When the
tip of the sonotrode approaches the tissue, the
ultrasonic energy, as a result of the high force of
acceleration and cavitation eﬀect, separates cells
from the conglomerate of tissues (fragmentation).
*e fragmented tissue can be aspirated as a semi-
liquid substance through the sonotrode hole,
freeing the defect from the formation of a stable
blood clot (Figure 5). *e end point is achieving
a condition in which the infrabony defect is free
from the granulation tissue as if we had performed
a surgical technique with the positive biological
consequences that were previously described
[17–20].
After CUSA treatment, the formation of a stable blood
clot was stimulated by avoiding any subgingival rinse.
No medications were prescribed advising the patients to
use painkillers (NSAIDs) if they experience postoperative
pain.
Subjects were reviewed at 7 days, 15 days, 1 month, 3
months, and 6months.*ese sessions included supragingival
professional mechanical plaque removal (PMPR) through
the use of Erythritol powder plus 14 μm (AIR-FLOW®
MASTER-EMS).
Clinical measurements of the defects and X-ray with bite
block were taken at baseline and 3 and 6months. CD and CG
acquired all clinical measurements and radiographs,
respectively.
*e following primary and secondary outcomes were
recorded.
(a) (b)
Figure 1: In the case of one or two wall defects, it was possible to use the transgingival approach through the very small access cavity on the
basis of the papilla. (a) *e sonotrode tip contacting the mucosa surface; (b) the small access after the CUSA treatment.
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Primary Outcomes
(i) Pocket closure proportion (PPD< 5mm)
(ii) Probing depth (PPD) reduction
(iii) CAL gain
(iv) Gingival recession
Secondary Outcomes
(i) Comfort and acceptability of the patient during
and after the procedure, as measured by in-
terviews, use of painkillers in the following three
days, and the visual analogue scale (VAS) after one
week;
(ii) Comfort and convenience of the operator during
the procedure, as measured by interviews at the
end of the procedure;
(iii) Adverse events.
Clinical data from all patients were entered into an
Excel ﬁle and checked for entry errors. Continuous var-
iables were expressed as the mean ± standard deviation
(SD). Dichotomous data were expressed as a percentage.
*e comparison between baseline and 6 months after
ﬂapless treatment was performed by applying a Wilcoxon
signed-rank test. All calculations were performed using
Stata version 11.1 (College Station, TX, USA). *e defect
was used as a statistical unit, and a P value <0.05 was
considered statistically signiﬁcant.
3. Results
A total of 14 defects in 11 patients were treated and included
in this case series. *e demographic and clinical baseline
characteristics of the 11 subjects are depicted in Table 1. *e
average age was 56± 8 years. Within the 14 treated defects,
ﬁve were in the mandible and nine in the maxilla. Seven
defects aﬀected the lateral and central incisors, and three
were adjacent to premolars and four to molars. *e mean
PPD at baseline was 8.6± 1.5mm, with an average gingival
recession of 2.6± 2.1mm, and therefore, the mean CAL was
11.1± 3mm. Table 2 shows the characteristics of the 14
infrabony defects included in this study.
Clinical measurements were taken during the last
follow-up visit, six months after CUSA treatment (Table 2).
*e CUSA procedure achieved pocket closure
(PPD< 5mm) in 86% of the defects (12 out of 14).
At that time point, themean values of PPD, CAL, and REC
were 3.9± 1.4mm, 6.8± 1.9mm, and 2.8± 1.6mm, re-
spectively; the diﬀerences with baseline data were statistically
signiﬁcant for PPD and CAL (P< 0.01). *e mean PPD re-
ductionwas 4.7± 2mm, andmeanCAL gain was 4.3± 2.2mm.
X-rays of the selected defects are presented in
Figures 6–9. At the end of the procedure, all patients re-
ported negligible discomfort; none took any painkillers in
the following week or more. *e mean VAS was 1.18± 1.11
(the distribution among the study population is shown in
Figure 10). *e VAS values ranged between 0 and 3; no
adverse event was recorded.
4. Discussion
Systematic review studies [33, 34] revealed that both con-
ventional nonsurgical and surgical therapies were eﬀective
methods for making improvements in terms of CAL gain
and PD reduction.
However, in recent studies inwhichMINSTwas performed
in initially deep pockets (PD> 6mm), there was a greater CAL
gain and PD reduction; the change in these clinical parameters
was similar, showing a mean CAL gain of 2.56mm and PD
reduction of 3.13mm in Ribeiro’s study andmean CAL gain of
2.78 and a PD reduction of 3.12mm in Nibali’s study [25, 26].
*ese data conﬁrm the initial hypothesis of the authors;
speciﬁcally, the use of minimally invasive strategies in non-
surgical therapy could lead to improvement of results com-
pared to the standard nonsurgical approach [25, 26].
*e present study tested a new ﬂapless approach to
further improve the results of debridement. For this reason,
the starting point of our research was one year after FMUD,
followed by repeated sessions of SPT [35].
*e primary idea was to eliminate old and capsulated
granulation tissue following the chronic process of
Aspiration
control
Power
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field
Figure 2: Ultrasound generator: hand-piece recognition and au-
tomatic adaptation; three frequencies: 25, 35, and 55 kHz; auto-
matic self-test of all of the important functions predeﬁned power
steps or direct adjustment; and optical and acoustical indicator.
Stack of piezoelectric 
quartzes
Sonotrode
Figure 3: *e stack of piezoelectric quartzes transforms the
electrical energy of the generator into a longitudinal, mechanical
vibration of the sonotrode tip.
Figure 4: Example of handpieces and sonostrodes.
Advances in Medicine 3
periodontitis, allowing the defects to have an appropriate
and stable new blood clot resulting from a nonsurgical
approach. *e ability of the surgical aspirator to reach all
areas of the defect with Mini tips, fragmenting and as-
pirating the tissue, makes this instrument particularly
suitable to this purpose [32].
Clinical results of the present study showed potential
beneﬁts of CUSA as an alternative to current subgingival
instruments. We obtained the resolution of 86% of the
periodontal pockets (12 out of 14), that is, a reduction of PD
at <5mm, a clinically relevant. CUSA has potential as
a method for reducing PD and gaining clinical attachment
in deep infrabony defects, showing mean diﬀerences of
4.7±1.9 and 4.3 ± 2.1, respectively. *is approach may be
clearly indicated in patients who are not candidates for
traditional surgery.
*e tested treatment has been proven to be safe, as no
local (i.e., recessions) or systemic adverse event was reported,
and no painkillers were necessary for any patient, and pain, as
recorded by VAS, was negligible, as demonstrated by the high
level of acceptance among patients. In addition, both of the
operators who performed the procedures (CG and CD) de-
scribed it as “simple,” “convenient,” and “rapid,” while in-
dicated, as amajor limit of the instrument, the lack of diﬀerent
tips in terms of dimensions and curvatures able to be adapted
to the varying tooth anatomy.
*e limitations of the present study are the relatively
small number of patients enrolled, although this was
designed as a preliminary study to test the potential beneﬁts
and risks of applying CUSA to gingival and periodontal
tissues. Another limitation is that, at present, such in-
strument is not available for the speciﬁc dental application,
and thus, we had to design and prepare a small number of ad
hoc tips. In addition, the cost of the CUSA is too expensive
(a) (b)
(c) (d)
Figure 5:*is sequence shows an infrasulcular approach to fragment the tissue.*e sonotrode was inserted in a periodontal pocket (a).*e
tip of the device, placed in contact with the tissues, destroys and emulsiﬁes cells that are irrigated and removed through a built-in suction
tube (b). After CUSA treatment, a blood clot ﬁlls the target area (c, d).
Table 1: Demographic and clinical baseline variables.
Patients
n � 11 %
Mean age 56± 8 (range 44–67)
Gender
Male 8 73
Female 3 27
ASA status
ASA I 11 100
Periodontal status
Severe chronic periodontitis 11 100
Race
Caucasian 11 100
Smoking status
Nonsmokers 9 82
Light smokers (<10 cigarettes) 2 18
ASA status based on the American Society of Anesthesiologists physical
status classiﬁcation system.
Table 2: Clinical variables before and after CUSA treatment.
Treated defects (n � 14)
P
valueBaseline post-FMUD
(mean± SD) 6-month reevaluationafter CUSA treatment(mean± SD)
PPD (mm) 8.6± 1.5 3.9± 1.4 <0.01
CAL (mm) 11.1± 3.0 6.8± 1.9 <0.01
REC (mm) 2.6± 2.1 2.8± 1.6 �0.41
FMUD, full-mouth ultrasonic debridement; CAL, clinical attachment loss;
REC, recessions; PPD, probing pocket depth. *e last column shows the P
value of the statistical analysis comparing baseline and reevaluation data
(statistically signiﬁcant: P< 0.05).
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(a) (b) (c)
Figure 7: Progression of X-rays showing bone remineralization. Baseline is 12months after (a) T0. In this case, the PD decreased from 8mm
((b) baseline) to 3mm (6 months (c) after CUSA). *e CAL gain was 4mm (from 10mm to 6mm).
(a) (b) (c)
Figure 8: Progression of X-rays showing bone remineralization. Baseline is 12months after (a) T0. In this case, the PD decreased from 9mm
((b) baseline) to 4mm (6 months (c) after CUSA). *e CAL gain was 6mm (from 15mm to 9mm).
(a) (b) (c)
Figure 6: Progression of X-rays showing bone remineralization. Baseline is 12 months after (a) T0. In this case, the PD decreased from
10mm ((b) baseline) to 4mm (6 months (c) after CUSA treatment). *e CAL gain was 7mm (from 15mm to 8mm).
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compared with ultrasonic devices currently used in the
routine clinical practice.
5. Conclusion
*e ﬂapless approach that was used for treating infrabony
defects achieved successful outcomes in terms of pocket
closure and clinical parameters.
*is approach was identiﬁed as a promising method to
amplify, and in secondary care, the results that are achievable
with nonsurgical therapy, promoting less morbidity than
any other surgical technique and providing patient satis-
faction. *is approach requires future randomized control
studies to better explain its potential and diﬀerent appli-
cation strategies.
Data Availability
*e data used to support the ﬁndings of this study are
available from the corresponding author upon request.
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(a) (b) (c)
Figure 9: Progression of X-rays showing bone remineralization. Baseline is 12 months after (a) T0. In this case, the PD decreased from
10mm ((b) baseline) to 4mm (6 months (c) after CUSA). *e CAL gain was 6mm (from 14mm to 8mm).
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Figure 10: Distribution of the 11 patients by the VAS score after CUSA treatment.
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